Timothy A. Springer, Director: Cartesian Therapeutics RNAC Buy · Filed 25/03/20

Trade details

Type: Insider buy
Amount: $855,719.51
Shares · price: 54,889 sh · $15.59 a share
Held after: 8,621,325 sh
Stock: Cartesian Therapeutics RNAC
Person: Timothy A. SpringerDirector
Trade date: 25/03/20
Filed: 25/03/20
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +0.6%

Cartesian Therapeutics trades, last 26 weeks

What else happened in Cartesian Therapeutics around then

Filed or reported within 30 days of the trade day · 25/02/18~25/04/19

Timothy A. Springer's recent trades

Timothy A. SpringerDirector
BuyTectonic Therapeutic
Buy
Tectonic Therapeutic
TECX
$875.9K
53,706 sh
$875.9K
Filed 25/04/11
Traded 25/04/11
Timothy A. SpringerDirector
BuyTectonic Therapeutic
Buy
Tectonic Therapeutic
TECX
$767.2K
45,858 sh
$767.2K
Filed 25/04/11
Traded 25/04/10
Timothy A. SpringerDirector
BuyTectonic Therapeutic
Buy
Tectonic Therapeutic
TECX
$237.1K
16,215 sh
$237.1K
Filed 25/04/11
Traded 25/04/09
Timothy A. SpringerDirector
BuyTectonic Therapeutic
Buy
Tectonic Therapeutic
TECX
$154.6K
9,478 sh
$154.6K
Filed 25/04/11
Traded 25/04/11
Timothy A. SpringerDirector
BuyTectonic Therapeutic
Buy
Tectonic Therapeutic
TECX
$135.4K
8,092 sh
$135.4K
Filed 25/04/11
Traded 25/04/10

Timothy A. Springer, Director — bought $855.7K of Cartesian Therapeutics RNAC · 54,889 sh @ $15.59 | Whalegun